Preclinical Development - Biomolecular - Translation

(W0930-02-07) Human Retinal Organoids Derived Extracellular Vesicles Loaded with Cannabinoids Attenuates Oxidative Stress Changes in ARPE-19 Cells

(T0930-02-10) A Mechanistic Ocular PK/PD Model with Systemic Target-Mediated Drug Disposition to Predict Human PK for Intravitreally Administered Anti-Tie2 Agonist

(M0930-02-10) Debulking of SARS-CoV-2 and Influenza Virus Strains by Plant Viral Trap Proteins in Chewing Gums to Decrease Infection and Transmission

(W0930-02-11) Anti-inflammatory and Analgesic Effects of a Highly Selective mPGES-1 Inhibitor

(M1030-02-07) Establishment of Preclinical Mechanistic In Vitro-In Vivo Correlations for Long-Acting Injectable Suspensions

(M1030-02-08) Biogenesis and Secretion Modulation of Brian Endothelial Cell-Derived Exosome for the Brain Delivery of Therapeutic Agents

(M1030-02-12) In Vitro Evaluation of CAR-T Cell Cytotoxicity Using Flow Cytometry for the Development of a Potency Assay

(W1230-02-10) Clinical Ocular Exposure Extrapolation Using PBPK Modeling and Simulation: Gatifloxacin Solution Case Study

(T1330-02-10) A PKPD Model to Predict the Therapeutic Index of Bispecific Antibody Targeting MerTK in Preclinical Mouse Model

(T1430-02-10) A Minimal PBPK-PD Model to Predict PK, PD, and Efficacy of Anti-CCR8 Antibody in Mice